Ezetimibe normalizes metabolic defects in mice lacking ABCG5 and ABCG8

The ATP binding cassette transporters ABCG5 (G5) and ABCG8 (G8) limit the accumulation of neutral sterols by restricting sterol uptake from the intestine and promoting sterol excretion into bile. Humans and mice lacking G5 and G8 (G5G8−/−) accumulate plant sterols in the blood and tissues. However,...

Full description

Bibliographic Details
Main Authors: Liqing Yu, Klaus von Bergmann, Dieter Lütjohann, Helen H. Hobbs, Jonathan C. Cohen
Format: Article
Language:English
Published: Elsevier 2005-08-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520329734
_version_ 1818715707016216576
author Liqing Yu
Klaus von Bergmann
Dieter Lütjohann
Helen H. Hobbs
Jonathan C. Cohen
author_facet Liqing Yu
Klaus von Bergmann
Dieter Lütjohann
Helen H. Hobbs
Jonathan C. Cohen
author_sort Liqing Yu
collection DOAJ
description The ATP binding cassette transporters ABCG5 (G5) and ABCG8 (G8) limit the accumulation of neutral sterols by restricting sterol uptake from the intestine and promoting sterol excretion into bile. Humans and mice lacking G5 and G8 (G5G8−/−) accumulate plant sterols in the blood and tissues. However, despite impaired biliary cholesterol secretion, plasma and liver cholesterol levels are lower in G5G8−/− mice than in wild-type littermates. To determine whether the observed changes in hepatic sterol metabolism were a direct result of decreased biliary sterol secretion or a metabolic consequence of the accumulation of dietary noncholesterol sterols, we treated G5G8−/− mice with ezetimibe, a drug that reduces the absorption of both plant- and animal-derived sterols. Ezetimibe feeding for 1 month sharply decreased sterol absorption and plasma levels of sitosterol and campesterol but increased cholesterol in both the plasma (from 60.4 to 75.2 mg/dl) and the liver (from 1.1 to 1.87 mg/g) of the ezetimibe-treated G5G8−/− mice. Paradoxically, the increase in hepatic cholesterol was associated with an increase in mRNA levels of HMG-CoA reductase and synthase.Together, these results indicate that pharmacological blockade of sterol absorption can ameliorate the deleterious metabolic effects of plant sterols even in the absence of G5 and G8.
first_indexed 2024-12-17T19:07:38Z
format Article
id doaj.art-a7e04addc0ac449dafc38f0357da9731
institution Directory Open Access Journal
issn 0022-2275
language English
last_indexed 2024-12-17T19:07:38Z
publishDate 2005-08-01
publisher Elsevier
record_format Article
series Journal of Lipid Research
spelling doaj.art-a7e04addc0ac449dafc38f0357da97312022-12-21T21:35:57ZengElsevierJournal of Lipid Research0022-22752005-08-0146817391744Ezetimibe normalizes metabolic defects in mice lacking ABCG5 and ABCG8Liqing Yu0Klaus von Bergmann1Dieter Lütjohann2Helen H. Hobbs3Jonathan C. Cohen4Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390Department of Clinical Pharmacology, University of Bonn, D-53105 Bonn, GermanyDepartment of Clinical Pharmacology, University of Bonn, D-53105 Bonn, GermanyDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390; McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX 75390; Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390To whom correspondence should be addressed.; Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390; McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX 75390; Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas, TX 75390The ATP binding cassette transporters ABCG5 (G5) and ABCG8 (G8) limit the accumulation of neutral sterols by restricting sterol uptake from the intestine and promoting sterol excretion into bile. Humans and mice lacking G5 and G8 (G5G8−/−) accumulate plant sterols in the blood and tissues. However, despite impaired biliary cholesterol secretion, plasma and liver cholesterol levels are lower in G5G8−/− mice than in wild-type littermates. To determine whether the observed changes in hepatic sterol metabolism were a direct result of decreased biliary sterol secretion or a metabolic consequence of the accumulation of dietary noncholesterol sterols, we treated G5G8−/− mice with ezetimibe, a drug that reduces the absorption of both plant- and animal-derived sterols. Ezetimibe feeding for 1 month sharply decreased sterol absorption and plasma levels of sitosterol and campesterol but increased cholesterol in both the plasma (from 60.4 to 75.2 mg/dl) and the liver (from 1.1 to 1.87 mg/g) of the ezetimibe-treated G5G8−/− mice. Paradoxically, the increase in hepatic cholesterol was associated with an increase in mRNA levels of HMG-CoA reductase and synthase.Together, these results indicate that pharmacological blockade of sterol absorption can ameliorate the deleterious metabolic effects of plant sterols even in the absence of G5 and G8.http://www.sciencedirect.com/science/article/pii/S0022227520329734ATP binding cassette transporter G5ATP binding cassette transporter G8sitosterolemiacholesterolbile
spellingShingle Liqing Yu
Klaus von Bergmann
Dieter Lütjohann
Helen H. Hobbs
Jonathan C. Cohen
Ezetimibe normalizes metabolic defects in mice lacking ABCG5 and ABCG8
Journal of Lipid Research
ATP binding cassette transporter G5
ATP binding cassette transporter G8
sitosterolemia
cholesterol
bile
title Ezetimibe normalizes metabolic defects in mice lacking ABCG5 and ABCG8
title_full Ezetimibe normalizes metabolic defects in mice lacking ABCG5 and ABCG8
title_fullStr Ezetimibe normalizes metabolic defects in mice lacking ABCG5 and ABCG8
title_full_unstemmed Ezetimibe normalizes metabolic defects in mice lacking ABCG5 and ABCG8
title_short Ezetimibe normalizes metabolic defects in mice lacking ABCG5 and ABCG8
title_sort ezetimibe normalizes metabolic defects in mice lacking abcg5 and abcg8
topic ATP binding cassette transporter G5
ATP binding cassette transporter G8
sitosterolemia
cholesterol
bile
url http://www.sciencedirect.com/science/article/pii/S0022227520329734
work_keys_str_mv AT liqingyu ezetimibenormalizesmetabolicdefectsinmicelackingabcg5andabcg8
AT klausvonbergmann ezetimibenormalizesmetabolicdefectsinmicelackingabcg5andabcg8
AT dieterlutjohann ezetimibenormalizesmetabolicdefectsinmicelackingabcg5andabcg8
AT helenhhobbs ezetimibenormalizesmetabolicdefectsinmicelackingabcg5andabcg8
AT jonathanccohen ezetimibenormalizesmetabolicdefectsinmicelackingabcg5andabcg8